BioCatalystWatch
RDHLWorkspace / RDHL / OverviewCompany library
RedHill Biopharma Ltd. logo

RedHill Biopharma Ltd.

RedHill Biopharma Ltd. (RDHL)

Website

Featured programme · RHB-102 (Bekinda®)

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Other pipelines

Trypsin-3 × Trypsin-2 × Trypsin-6 × Trypsin-1 × Matriptase-1

Trypsin-3 × Trypsin-2 × Trypsin-6 × Trypsin-1 × Matriptase-1

Trypsin-3 × Trypsin-2 × Trypsin-6 × Trypsin-1 × Matriptase-1

Trypsin-3 × Trypsin-2 × Trypsin-6 × Trypsin-1 × Matriptase-1

Trypsin-3 × Trypsin-2 × Trypsin-6 × Trypsin-1 × Matriptase-1

Opaganib + darolutamide

SPHK2 (SK2)

PreINDP1P2P3FilingApproved
RHB-106

PreINDP1P2P3FilingApproved

Partner / License out

Approved / commercial

PreINDP1P2P3FilingApproved

History / paused

SPHK2 (SK2)

PreINDP1P2P3FilingApproved

SPHK2 (SK2)

SPHK2 (SK2)

PreINDP1P2P3FilingApproved

SPHK2 (SK2)

PreINDP1P2P3FilingApproved

SPHK2 (SK2)

SPHK2 (SK2)

PreINDP1P2P3FilingApproved

SPHK2 (SK2)

SPHK2 (SK2)

SPHK2 (SK2)

SPHK2 (SK2)

SPHK2 (SK2)

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

RDHL PR & News

RDHL SEC archive